May 20, 2025 09:15AM Petros Pharmaceuticals Partners with Innolitics, a Leading Software-as-a-Medical-Device Developer

May 6, 2025 09:22AM Petros Pharmaceuticals (PTPI) Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform

May 6, 2025 09:20AM Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform

May 1, 2025 09:24AM Petros Pharmaceuticals, Inc (PTPI) Developing First-in-Industry SaaS Platform Utilizing AI and Electronic Health Records Intended to Facilitate Rx-OTC Switches

May 1, 2025 09:20AM Petros Pharmaceuticals Developing First-in-Industry SaaS Platform Utilizing AI and Electronic Health Records Intended to Facilitate Rx-OTC Switches

Apr 29, 2025 09:23AM Petros Pharmaceuticals (PTPI) Proprietary Technology Platform Aligns with April 15, 2025 President Trump Executive Order Advancing Rx-to-OTC Reclassification Reforms

Apr 29, 2025 09:20AM Petros Proprietary Technology Platform Aligns with April 15, 2025 President Trump Executive Order Advancing Rx-to-OTC Reclassification Reforms

Mar 20, 2025 09:17AM Petros Pharmaceuticals, (PTPI) to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications

Mar 20, 2025 09:15AM Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications

Feb 25, 2025 09:21AM Petros Pharmaceuticals' (PTPI) Proprietary Technology Demonstrates Positive Data in Pivotal Study

Feb 25, 2025 09:20AM Petros Pharmaceuticals' Proprietary Technology Demonstrates Positive Data in Pivotal Study

Feb 18, 2025 09:30AM Petros Pharmaceuticals announces pricing of $9.6 million public offering

Feb 18, 2025 09:25AM Petros Pharmaceuticals Announces Pricing of $9.6 Million Public Offering of Common Stock and Warrants

Jan 7, 2025 09:15AM Petros Pharmaceuticals Strategically Positioned to Benefit as Technology Leader from Newly Approved FDA OTC Final Rules

Dec 19, 2024 09:15AM Petros Pharmaceuticals Featured in “New Era of Healthcare, AI, Data and Consumer Empowerment”

Dec 17, 2024 09:00AM Proprietary Technology Addressing the Rx-to-OTC Switch Self-Care Market Valued at over $38 Billion annually

Sep 11, 2024 09:21AM Petros Pharmaceuticals (PTPI) Executes Successful Initial Test for App Comprehension as Part of FDA Pathway for Over-the-Counter Access for STENDRA

Sep 11, 2024 09:15AM Petros Pharmaceuticals Executes Successful Initial Test for App Comprehension as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil)

Sep 3, 2024 09:00AM Petros Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Jul 29, 2024 09:24AM Petros (PTPI) Pivotal Statistically Significant Self Selection Study Shows Stronger Results with Proprietary Technology Application as Part of FDA Pathway for OTC Access for STENDRA

Jul 29, 2024 09:20AM Petros Pharmaceuticals' Pivotal Statistically Significant Self Selection Study Shows Stronger Results with Proprietary Technology Application as Part of FDA Pathway for Over-the-Counter Access for STE

Jul 16, 2024 09:07AM Petros Pharmaceuticals' (PTPI) STENDRA Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance

Jul 16, 2024 09:00AM Petros Pharmaceuticals’ STENDRA(R) (avanafil) Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance